<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000382.v2.p1" parentStudy="phs000382.v2.p1" createDate="2013-09-06" modDate="2013-09-06">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Joseph G. Gleeson, MD</td><td>University of California, San Diego, CA, and Department of Neuroscience, Howard Hughes Medical Institute, USA</td></tr>
		<tr><td>Funding Source</td><td>RNS048453B &quot;Molecular Characterization of Joubert Syndrome&quot;</td><td>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Sequencing Center</td><td>Center for Inherited Disease Research (CIDR)</td><td>Johns Hopkins University, Baltimore, MD, USA</td></tr>
		<tr><td>Funding Source for Sequencing</td><td>HHSN268201100011I</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source for Sequencing</td><td>HHSN268200782096C</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>CIDR Whole Exome Sequencing in Joubert Syndrome</StudyNameEntrez>
	<StudyNameReportPage>CIDR Whole Exome Sequencing in Joubert Syndrome</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cohort</StudyType>
		<StudyType>Family</StudyType>
		<StudyType>Exome Sequencing</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The purpose of this study is to identify new genetic causes of neurodevelopmental diseases (NDDs) in the Joubert syndrome (JS) spectrum. Joubert syndrome is a recessive disease characterized by cerebellar vermis hypoplasia. Our currently funded NINDS award entitled "Molecular characterization of Joubert syndrome" seeks to identify new genetic causes through a variety of molecular strategies. Although our previous strategies involved whole genome SNP-scans, followed by candidate gene sequencing to arrive at identification of new JS causes, we have recently moved to Whole Exome Sequencing (WES) as a highly efficient methodology that is optimized for recessive disease. In this pilot project, CIDR has sequenced DNA on probands from 20 inbred families with JS spectrum disorders in which known causes have been excluded, that have not previously undergone genome-wide SNP scans. These paired end reads will be subject to our established bioinformatics pipeline including HOMOZGYOSITY, SNP and INDEL callers in our lab to identify potentially deleterious sequence changes (PDSC). This is followed by analysis to include testing each PDSC for segregation in the whole pedigree, for occurrence in a ethnically-matched cohort, as well as a defined patient cohort patients, in order to validate new NDD genes.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>The inclusion criteria are these cases with likely inherited NDD for which the genetic cause is not known or is not obvious and falls within the Joubert syndrome spectrum to include the MESH terms listed. Parents must be consanguineous, and there must be more than one affected member per family. In some instances, these will be affected siblings and in other families this will be affected cousins. The exclusion criteria are those cases likely due to non-genetic factors such as environmental or pregnancy/labor/delivery issues, any cases with neurodegenerative components, or cases in which the genetic cause is obvious or already known.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21679365"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21263138"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21258341"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20637498"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20512146"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20232449"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20081859"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19764032"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19668216"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19058225"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18674751"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18565097"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17564967"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16682970"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16453322"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15786477"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15467982"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Joubert syndrome 1"/>
		<Disease vocab_source="MESH" vocab_term="Developmental Delay Disorders"/>
		<Disease vocab_source="MESH" vocab_term="Cerebellar Ataxias"/>
		<Disease vocab_source="MESH" vocab_term="COACH syndrome"/>
		<Disease vocab_source="MESH" vocab_term="Polycystic Kidney, Autosomal Recessive"/>
		<Disease vocab_source="MESH" vocab_term="Spastic Paraplegia, Hereditary"/>
		<Disease vocab_source="MESH" vocab_term="Walker-Warburg Syndrome"/>
		<Disease vocab_source="MESH" vocab_term="Mental Retardation"/>
		<Disease vocab_source="MESH" vocab_term="Leber Congenital Amaurosis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Joseph G. Gleeson, MD</AttName>
			<Institution>University of California, San Diego, CA, and Department of Neuroscience, Howard Hughes Medical Institute, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>RNS048453B &quot;Molecular Characterization of Joubert Syndrome&quot;</AttName>
			<Institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Sequencing Center">
			<AttName>Center for Inherited Disease Research (CIDR)</AttName>
			<Institution>Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Funding Source for Sequencing">
			<AttName>HHSN268201100011I</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source for Sequencing">
			<AttName>HHSN268200782096C</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>In 2000, we began to recruit families from the Middle East. We have identified several genes for Joubert syndrome and related disorders (JSRD) using homozygosity mapping. We expect that exome sequencing will increase the efficiency of gene discovery in these families.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="ARU" longName="Academic research use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NINDS</DacName>
      <DacFullName>National Institute of Neurological Disorders and Stroke</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000382.v2.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000382.v2.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000382.v2.p1" FileName="DUC-CIDR_NINDS_Whole_Exome_Sequencing_in_Joubert_Syndrome.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Academic research use</ConsentName>
        <ConsentAbbrev>ARU</ConsentAbbrev>
        <UseLimitation>Academic research use only</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd003655.1" type="consent-form" createDate="2011-08-09" modDate="2011-08-09">
      <OrigName>ParentConsentform.pdf</OrigName>
      <DisplayName>Parental Consent Form</DisplayName>
      <Description>Parental Consent Form</Description>
      <displayStatus>stage-1</displayStatus>
      <xmlStatus>preview</xmlStatus>
    </Document>
    <Document phd="phd003656.1" type="protocol" createDate="2011-08-09" modDate="2011-08-09">
      <OrigName>StudyDataAnalysis.doc</OrigName>
      <DisplayName>Study Data Analysis</DisplayName>
      <Description>Study Data Analysis</Description>
      <displayStatus>stage-1</displayStatus>
      <xmlStatus>preview</xmlStatus>
    </Document>
    <Document phd="phd003657.1" type="protocol" createDate="2011-08-09" modDate="2011-08-09">
      <OrigName>StudyDataSource.doc</OrigName>
      <DisplayName>Study Data Source</DisplayName>
      <Description>Study Data Source</Description>
      <displayStatus>stage-1</displayStatus>
      <xmlStatus>preview</xmlStatus>
    </Document>
    <Document phd="phd003658.1" type="protocol" createDate="2011-08-09" modDate="2011-08-09">
      <OrigName>StudyDesign.doc</OrigName>
      <DisplayName>Study Design</DisplayName>
      <Description>Study Design</Description>
      <displayStatus>stage-1</displayStatus>
      <xmlStatus>preview</xmlStatus>
    </Document>
  </Documents>



</Study>

</Studies>

</GaPExchange>
